Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Hubbard John W Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns: Granted 935 shares @ $0
Granted 1,065 options to buy @ $3.58, valued at $3.8k
05/12/2023 4 Hubbard John W (Director) has filed a Form 4 on Science 37 Holdings, Inc.
Txns: Exercised 40,983 restricted stock units @ $0
Granted 494,853 restricted stock units @ $0
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Hubbard John W (Director) has filed a Form 4 on Science 37 Holdings, Inc.
Txns: Granted 40,983 restricted stock units @ $0
10/12/2021 4 Hubbard John W (Director) has filed a Form 4 on Science 37 Holdings, Inc.
Txns: Granted 50,802 options to buy @ $0
Granted 27,575 options @ $10.05, valued at $277.1k
10/08/2021 4 Hubbard John W (Director) has filed a Form 4 on Science 37 Holdings, Inc.
Txns: Granted 403,896 options @ $0.28, valued at $113.1k
10/08/2021 3 Hubbard John W (Director) has filed a Form 3 on Science 37 Holdings, Inc.
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns: Granted 13,393 shares @ $0
Granted 22,606 options to buy @ $2.8, valued at $63.3k
06/07/2019 4 Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns: Granted 75,000 options to buy @ $1.03, valued at $77.3k
06/08/2018 4 Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns: Granted 50,000 options to buy @ $0.6, valued at $30k
Exercised 17,949 restricted stock units @ $0
06/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/09/2016 4 Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC
Txns: Granted 14,000 options to buy @ $7.63, valued at $106.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy